HIF1A and neoplasm: Both the suppression of HIF-1 activity by zinc(II) supplementation and the targeted knockdown of HIF-1α expression by siRNA significantly enhanced chemosensitivity in cancer cells and suppressed chemoresistant xenograft tumor growth in vivo.